{"title":"SYNTHESIS AND EVALUATION OF ANTIMICROBIAL ACTIVITY OF ARYLAZOLE DERIVATIVES","authors":"Ahmed Mancy","doi":"10.21608/AJPS.2019.70236","DOIUrl":null,"url":null,"abstract":"Antibiotics are a cornerstone of medical treatment for various bacterial infections and are prescribed at a rate that exceeds the limit of prescribing. Phenylthiazoles were reported previously as a new scaffold that possesses antibacterial activity against an array of clinically-relevant strains of multidrug-resistant staphylococci.The structure-activity-relationships (SAR) of phenylthiazoles revealed important structural features necessary for their antibacterial activity: a nitrogenous head and a lipophilic tail. Incorporating the acetylene part in analogues with a prolonged half-life, while the cyclic nitrogenous extention revealed the most potent analogue. In the current work, advantageous moieties have been tethered together to produce a new scaffold of phenylthiazole with the objective of promoting new scaffold enhancing both antimicrobial resistance activity and drug-like properties. Among the tested phenylthiazoles, compounds 14 and 16 were found to exert a bactericidal activity against MRSA. The pharmacokinetic profile of compound 15 was significantly enhanced against biofilm of the bacteria.","PeriodicalId":7603,"journal":{"name":"Al-Azhar Journal of Pharmaceutical Sciences","volume":"14 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Al-Azhar Journal of Pharmaceutical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21608/AJPS.2019.70236","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Antibiotics are a cornerstone of medical treatment for various bacterial infections and are prescribed at a rate that exceeds the limit of prescribing. Phenylthiazoles were reported previously as a new scaffold that possesses antibacterial activity against an array of clinically-relevant strains of multidrug-resistant staphylococci.The structure-activity-relationships (SAR) of phenylthiazoles revealed important structural features necessary for their antibacterial activity: a nitrogenous head and a lipophilic tail. Incorporating the acetylene part in analogues with a prolonged half-life, while the cyclic nitrogenous extention revealed the most potent analogue. In the current work, advantageous moieties have been tethered together to produce a new scaffold of phenylthiazole with the objective of promoting new scaffold enhancing both antimicrobial resistance activity and drug-like properties. Among the tested phenylthiazoles, compounds 14 and 16 were found to exert a bactericidal activity against MRSA. The pharmacokinetic profile of compound 15 was significantly enhanced against biofilm of the bacteria.